203 related articles for article (PubMed ID: 12869408)
1. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.
Tsao AS; McDonnell T; Lam S; Putnam JB; Bekele N; Hong WK; Kurie JM
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):660-4. PubMed ID: 12869408
[TBL] [Abstract][Full Text] [Related]
2. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
[TBL] [Abstract][Full Text] [Related]
3. Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.
Balsara BR; Pei J; Mitsuuchi Y; Page R; Klein-Szanto A; Wang H; Unger M; Testa JR
Carcinogenesis; 2004 Nov; 25(11):2053-9. PubMed ID: 15240509
[TBL] [Abstract][Full Text] [Related]
4. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
6. Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.
Mukohara T; Kudoh S; Matsuura K; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Inoue K; Wanibuchi H; Fukushima S; Yoshikawa J
Anticancer Res; 2004; 24(1):11-7. PubMed ID: 15015570
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
Lee HY
Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
[TBL] [Abstract][Full Text] [Related]
9. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.
Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR
Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735
[TBL] [Abstract][Full Text] [Related]
10. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
12. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
[TBL] [Abstract][Full Text] [Related]
13. Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium.
Wu X; Xiao Z; Chen Z; Li C; Li J; Feng X; Yi H; Liang S; Chen P
Pathol Int; 2004 Oct; 54(10):765-73. PubMed ID: 15482566
[TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
Kurie JM; Lee JS; Khuri FR; Mao L; Morice RC; Lee JJ; Walsh GL; Broxson A; Lippman SM; Ro JY; Kemp BL; Liu D; Fritsche HA; Xu X; Lotan R; Hong WK
Clin Cancer Res; 2000 Aug; 6(8):2973-9. PubMed ID: 10955773
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium.
Chang YS; Chung JH; Shin DH; Chung KY; Kim YS; Chang J; Kim SK; Kim SK
Yonsei Med J; 2004 Jun; 45(3):435-42. PubMed ID: 15227730
[TBL] [Abstract][Full Text] [Related]
16. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
[TBL] [Abstract][Full Text] [Related]
17. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E
Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
20. High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation.
Hilbe W; Auberger J; Dirnhofer S; Schmid T; Erdel M; Duba HC
Oncol Rep; 2006 May; 15(5):1233-40. PubMed ID: 16596192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
